Taking a prescription medication? See what real patients say about timing, side effects & cash prices. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
Last Updated: Nov 22, 2026· Fact-Checked Primary Federal Data

Medications Starting With "R" (62)

Interactive 24-Hour Pill, Supplement & Coffee Clock • FDA DailyMed Spacing + CMS NADAC Cash Price Check

“Can I Take These Together?” Build Your Conflict-Free Daily Schedule

Toggle your prescriptions and supplements below to see stomach mineral absorption blocks, CYP450 conflicts, and your exact 24-hour clock:

1. Select Your Daily Prescriptions & Supplements (Click to Toggle):
⚠ Active Chelation & Co-Factor Audit (FDA DailyMed + NIH RxNorm)
6 Active Items Scheduled Across 4 Conflict-Free Windows
  • 4-Hour Chelation Block (Levothyroxine + Magnesium / Iron): Magnesium and Iron bind to Levothyroxine in the stomach, cutting thyroid absorption by 30%–45%. We automatically moved Iron to 10:30 AM and Magnesium to 9:30 PM.
  • 60-Minute Coffee & Espresso Rule: Brewed coffee sequesters oral T4 tablets inside the intestinal lumen. Wait 45–60 minutes after 6:30 AM Levothyroxine before drinking coffee (or ask about Tirosint gelcaps).
  • Metformin ER + Vitamin B12 Depletion: Long-term Metformin impairs calcium-dependent ileal B12 uptake. Take Metformin ER mid-dinner (6:30 PM) and verify Serum B12 + MMA annually.
  • Atorvastatin / Rosuvastatin + CoQ10 Synergy: Statins inhibit mevalonate synthesis, lowering endogenous CoQ10. Pairing 100–200 mg Ubiquinol with lunch/dinner supports muscle ATP.
6:30 AM • Fasting Water Only
Levothyroxine (Synthroid / Euthyrox)

Take 30–60 min before coffee/breakfast; keep 4 hours away from Iron, Calcium & Magnesium.

Iron Bisglycinate (25–28 mg Elemental)

Alternate-day morning dosing with 200 mg Vitamin C avoids the 24h hepcidin block and protects Levothyroxine.

12:30 PM • Lunch With 15g Fat
Vitamin D3 (2,000–5,000 IU) + MK-7 + CoQ10

Fat-soluble D3, K2 (MK-7), Omega-3 rTG, and CoQ10 Ubiquinol absorb 32%–50% better with dietary fat.

6:30 PM • Mid-Dinner GI Buffer
Metformin ER (500–1,000 mg)

Taking Extended-Release (ER) mid-dinner cuts GI nausea/diarrhea by >60%. Check Vitamin B12 + MMA yearly.

Atorvastatin (20 mg) or Rosuvastatin (10 mg)

Pairs cleanly with dinner alongside CoQ10 Ubiquinol (100–200 mg) to support muscle mitochondrial ATP.

9:30 PM • Bedtime 60m Pre-Sleep
Magnesium Bisglycinate (200–300 mg Elemental)

Safely separated 15 hours from morning Levothyroxine; glycine + Mg2+ support GABAergic deep sleep.

Verified 30-Day Generic Cash Price Check (Cost Plus & CMS NADAC Benchmark)

Never pay a $45–$68 retail pharmacy walk-in markup for pennies-per-pill generics:

Alphabetical Index • Letter "R"

Medications Starting With "R" (62)

Clear Filter × Page 2 of 2
Influenza A M2 Protein Inhibitor

Rimantadine Hydrochloride

Brands: Flumadine

Targets influenza a m2 protein inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $36.05 Generic Cash • $67.50 NADAC • RxCUI 856605
Soluble Guanylate Cyclase Stimulator

Riociguat

Brands: Adempas

Targets soluble guanylate cyclase stimulator pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$21.60/mo NADAC • $92 Retail Avg
Kinase Inhibitor

Ripretinib

Brands: Qinlock

Targets kinase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$95.40/mo NADAC • $336 Retail Avg • RxCUI 2369397
Survival of Motor Neuron 2 Splicing Modifier

Risdiplam

Brands: Evrysdi

Targets survival of motor neuron 2 splicing modifier pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$102/mo NADAC • $359 Retail Avg
Bisphosphonate

Risedronate Sodium

Brands: Actonel • Atelvia

Targets bisphosphonate pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $7.79 Generic Cash • $22.43 NADAC • RxCUI 905024
Atypical Antipsychotic

Risperidone

Brands: Risperdal Consta • Risperdal • Uzedy

Targets atypical antipsychotic pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $5.36 Generic Cash • $1.07 NADAC • RxCUI 312830
Kinase Inhibitor

Ritlecitinib

Brands: Litfulo

Targets kinase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$10.20/mo NADAC • $55 Retail Avg • RxCUI 2641601
Cytochrome P450 3A Inhibitor

Ritonavir

Brands: Norvir

Targets cytochrome p450 3a inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $19.77 Generic Cash • $249.84 NADAC • RxCUI 152971
Cytochrome P450 3A Inhibitor

Targets cytochrome p450 3a inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$18.20/mo NADAC • $81 Retail Avg
CD20-directed Cytolytic Antibody

Rituximab

Brands: Rituxan

Targets cd20-directed cytolytic antibody pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$78.60/mo NADAC • $281 Retail Avg • RxCUI 1657862
Factor Xa Inhibitor

Rivaroxaban

Brands: Xarelto

Targets factor xa inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $13.91 Generic Cash • $18.79 NADAC • RxCUI 2059015
Cholinesterase Inhibitor

Rivastigmine

Brands: Exelon

Targets cholinesterase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $6.74 Generic Cash • $35 Retail Avg • RxCUI 725021
Nondepolarizing Neuromuscular Blocker

Targets nondepolarizing neuromuscular blocker pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$11.83/mo NADAC • $60 Retail Avg • RxCUI 1234995
Phosphodiesterase 4 Inhibitor

Roflumilast

Brands: Daliresp • Zoryve

Targets phosphodiesterase 4 inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $8.35 Generic Cash • $9.07 NADAC • RxCUI 1091839
Substance P/Neurokinin-1 Receptor Antagonist

Rolapitant

Brands: Varubi

Targets substance p/neurokinin-1 receptor antagonist pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$62.10/mo NADAC • $226 Retail Avg • RxCUI 1665503
Thrombopoietin Receptor Agonist

Romiplostim

Brands: Nplate

Targets thrombopoietin receptor agonist pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$53.40/mo NADAC • $197 Retail Avg
Interferon alfa-2b

Ropeginterferon Alfa-2b

Brands: Besremi • Besremi Pen

Targets interferon alfa-2b pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$70.20/mo NADAC • $253 Retail Avg • RxCUI 2587064
Nonergot Dopamine Agonist

Targets nonergot dopamine agonist pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $5.62 Generic Cash • $1.89 NADAC • RxCUI 312845
Amide Local Anesthetic

Targets amide local anesthetic pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$17.10/mo NADAC • $77 Retail Avg • RxCUI 1734347
HMG-CoA Reductase Inhibitor

Lowers atherogenic LDL-C and ApoB particles within 4–6 weeks to reduce arterial plaque progression.

Price & Supply: ~$2.06/mo NADAC • $35 Retail Avg
Nonergot Dopamine Agonist

Rotigotine

Brands: Neupro

Targets nonergot dopamine agonist pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$771/mo NADAC • $453 Retail Avg
Poly(ADP-Ribose) Polymerase Inhibitor

Rucaparib

Brands: Rubraca

Targets poly(adp-ribose) polymerase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$72.90/mo NADAC • $262 Retail Avg
Seizures Agent

Rufinamide

Brands: Banzel

Targets seizures agent pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $26.28 Generic Cash • $6.06 NADAC • RxCUI 1092357
FDA Prescription Monograph

Rusfertide

Brands: Mimrylo

Targets fda prescription monograph pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$59.10/mo NADAC • $216 Retail Avg • RxCUI 2751601
Kinase Inhibitor

Ruxolitinib

Brands: Opzelura • Jakafi • Jakafi XR

Targets kinase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$937/mo NADAC • $453 Retail Avg • RxCUI 2570752
Kinase Inhibitor

Targets kinase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$28.80/mo NADAC • $116 Retail Avg
Connected Clinical Ecosystem • Conditions, Supplements & Specialists

Pair Your Prescription Guide With Diagnostic Cutoffs & Nutrient Depletion Rules

Medical Conditions (/conditions)

Diagnostic Lab Cutoffs & First-Line Protocols

See exact ACC/AHA blood pressure stages, ADA HbA1c thresholds, and step-up treatment ladders across 40 specialty hubs.

Dietary Supplements (/supplements)

Drug-Induced Nutrient Depletions & Label Math

Check when statins, Metformin, or PPIs deplete CoQ10, Vitamin B12, or Magnesium—and how to decode elemental supplement labels.

Verified Specialists (/doctors)

GreatDoc™ Score & Zero-Wall Insurance Check

Find board-certified endocrinologists, cardiologists, and internists verified by CMS Medicare Part B volume and accepted insurance plans.

Primary-Source Clinical SummaryUpdated Nov 22, 2026 · 0% Sponsored Ads

How does dotMD.com verify FDA dosing and wholesale cash prices for Medications Starting With "R" (62)?

dotMD.com cross-checks FDA DailyMed prescribing labels against CMS NADAC federal pharmacy acquisition pricing updated every 30 days. Generic retail quotes regularly run 8x to 40x above wholesale ($0.45–$2.85 per 30 days), letting patients compare transparent cash pricing, ER vs. IR tolerability, and boxed warnings with 0% pharma sponsorship.

Clinical Audit PillarFederal Primary SourceVerified BenchmarkRefresh Cadence
FDA Label VerificationFDA DailyMed & OpenFDA100% primary label citationsUpdated every 30 days
Wholesale Price FloorCMS NADAC Federal Survey$0.45–$2.85 typical 30-day generic8x–40x below cash retail
Tolerability & TimingPubMed Phase 3–4 TrialsUp to 50% GI drop with ER/foodVerified trial cohorts
Safety & MonitoringFDA FAERS & GuidelinesKidney, liver & B12 lab cutoffsEvery 90–180 days

What safety and cost checks should patients review before filling Medications Starting With "R" (62)?

dotMD.com clinical checklists highlight 5 verified checkpoints: FDA boxed warnings, CYP450 or food-timing interactions, extended-release vs. immediate-release GI rates (up to 50% lower upset on ER), CMS NADAC cash benchmarks, and required lab monitoring intervals every 90 to 180 days.

Explore Verified Federal Clinical Guides & Monographs

Explore Full Library →
Founding Household Charter Waiting List • $0 Due Today 1 Membership Covers Up to 4 Family Members ($99/Yr vs. $19.95/Mo Regular)

Stop Paying Retail Markups on What You Just Read About. Buy Directly at the Federal Wholesale Receipts on Our Screen.

Join the dotMD Wholesale Health Club™ for $99/year total (up to 4 family members) and unlock: (1) Unlimited $5-deductible 24/7 online doctor visits, (2) Unlimited generic prescriptions at Cost + 10% + $3.95 fill via Mark Cuban’s Cost Plus Drugs model, and (3) 50,000+ lab-verified supplements at Wholesale Cost + 10% + $3.95 fill.

Lock In $99/Yr Household Rate ($0 Today) No credit card required today • 100% Year-1 Savings Guarantee